Symptomtext
vaccine on a 230 pound female, used a 1 inch needle, not confident that it reached the muscle; Wrong Route of Administration; This case was reported by a pharmacist via call center representative and described the occurrence of wrong technique in product usage process in a 62-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 5723N, expiry date 19th November 2022) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th April 2022, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 6th April 2022, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced wrong technique in product usage process and inappropriate route of vaccination. On an unknown date, the outcome of the wrong technique in product usage process and inappropriate route of vaccination were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 8-Apr-2022 Reporter's comments The registered pharmacist administered Boostrix vaccine to the patient and used a 1 inch needle. The reporter was not confident that it reached the muscle and was wondering if he should repeat the dose. The consent to follow up was given via postal. Additional Supportive Information: The pharmacist administered Boostrix to a patient, and used 1 inch needle and reporter was not confident that it reached the muscle, which led to wrong technique in product usage process and inappropriate route of vaccination.